Backed by data from the phase 3 SatraGO trials, satralizumab has the potential to offer patients a convenient, at-home treatment option.

The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Pfizer and Amgen are developing monthly GLP-1 shots — a departure from ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

Some medications must be given by an intravenous (IV) injection or infusion. This means they’re sent directly into your vein using a needle or tube. With IV therapy, a thin plastic tube called an IV ...

Because both Ozempic and Wegovy contain the exact same active ingredient, understanding the differences in their dosages, approved uses, titration schedules, and safety warnings will help you work ...

Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists help manage blood sugar in type 2 diabetes. They may also support ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. The WPA was part of Franklin D.

A cortisone shot is an injection containing a steroid. A person with hip pain due to injury or disease may receive a cortisone shot to help treat pain and inflammation in the hip joint. While ...

As we age, we notice many changes in our bodies. Many obvious changes take place in our skin. Do you have wrinkles and facial lines that you want to get rid of without surgery? Well, the vampire ...

Priority review positions satralizumab as a potentially practice-shifting alternative to IV IGF-1R inhibitors, primarily differentiated by subcutaneous self-administration and at-home dosing. Two ...